Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-18

Clinical Trial Update: Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating intravenous immunoglobulin with or without cyclophosphamide for pemphigus vulgaris was terminated; results were posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: NYU Langone Health | Conditions: Pemphigus Vulgaris | Phase 2 | Status: TERMINATED | Results posted: 2016-02-18